MedTrace Logo

The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

NCT01699360 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2012-10-03

No results posted yet for this study

Summary

The aim of this study is to evaluate the potential of endogenous cortisol and cortisone metabolism as a biomarker for immunosuppressive agents disposition in Chinese renal transplant recipients. If the blood concentrations of immunosuppressants can be predicted successfully, this new probe may take place of current drug monitoring post transplantation.

Conditions

  • Kidney Transplantation

Interventions

DRUG

Cyclosporine A, Tacrolimus, Sirolimus

Sponsors & Collaborators

  • Central South University

    lead OTHER

Principal Investigators

  • Zeneng cheng, doctor · Central South University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01699360 on ClinicalTrials.gov